The Gross Margin of Harbin Pharmaceutical Group Co Ltd (600664.SS) is 26.02%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 26.02% |
| 2022-12-31 | 24.41% |
| 2021-12-31 | 23.31% |
| 2020-12-31 | 20.91% |
| 2019-12-31 | 23.73% |
| 2018-12-31 | 26.78% |
| 2017-12-31 | 25.89% |
| 2016-12-31 | 26.20% |
| 2015-12-31 | 24.42% |
| 2014-12-31 | 27.03% |